HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stent-graft repair for blunt traumatic aortic injury as the new standard of care: is there evidence?

Abstract
Designed to treat degenerative aneurysms of the thoracic and abdominal aorta, endovascular stent-grafts have been increasingly employed as an off-label emergency treatment for blunt traumatic aortic injury (BTAI). In this review we explore the controversies associated with thoracic endovascular aortic repair (TEVAR) for BTAI. Early versus delayed treatment of aortic injuries is controversial, and stent-graft repair has further confused the issue of timing the repair. The diagnosis and management of minimal aortic injuries remains elusive. We analyze the available literature pertaining to BTAI, including the recent multicenter prospective trial from the American Association for the Surgery of Trauma. The strengths and weaknesses of the stent-grafts currently available for use in the US are examined to provide insight into which graft may be best suited for BTAI at the present time. Also of importance, we offer recommendations regarding clinical situations in which TEVAR should not be the first line therapy for BTAI. We conclude with a discussion of upcoming trials and new devices that will shape the future of endovascular treatment of BTAI.
AuthorsMarvin D Atkins, Christopher J Marrocco, W Todd Bohannon, Ruth L Bush
JournalJournal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (J Endovasc Ther) Vol. 16 Suppl 1 Pg. I53-62 (Feb 2009) ISSN: 1545-1550 [Electronic] United States
PMID19317586 (Publication Type: Journal Article, Review)
Topics
  • Aorta, Thoracic (injuries, pathology, surgery)
  • Blood Vessel Prosthesis
  • Blood Vessel Prosthesis Implantation (adverse effects, instrumentation, standards)
  • Evidence-Based Medicine
  • Guideline Adherence
  • Humans
  • Patient Selection
  • Practice Guidelines as Topic
  • Product Labeling
  • Prosthesis Design
  • Quality of Health Care (standards)
  • Risk Assessment
  • Severity of Illness Index
  • Stents
  • Time Factors
  • Treatment Outcome
  • Wounds, Nonpenetrating (pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: